Search

Excited atomic states of neutral einsteinium were investigated by resonant laser ionization using 10 pg (2×10^{10} atoms) of ^{254}Es. Ten transitions from the 5f^{11}7s^{2}^{4}I_{15/2}^{o} ground state to even-parity states were investigated in detail, via studies of lifetimes and further excitation steps into higher-lying odd-parity states below and above the first ionization potential. This led to the identification of 37 previously unknown odd-parity energy levels in the region between 37000 and 42500cm^{−1} and a number of autoionizing states, which ensure a high ion yield in resonant ionization. Rydberg states were identified and the corresponding Rydberg series converging either to the ionic ground or an excited state were analyzed to determine the first ionization potential of einsteinium to a value of E_{IP}=51364.58(14)_{stat}(50)_{sys}cm^{−1}, improving the previous result by a factor of four.

The atomic structure of californium is probed by two-step resonance ionization spectroscopy. Using samples with a total amount of about 2×1010 Cf atoms (ca. 8.3 pg), ground-state transitions as well as transitions to high-lying Rydberg states and auto-ionizing states above the ionization potential are investigated and the lifetimes of various atomic levels are measured. These investigations lead to the identification of efficient ionization schemes, important for trace analysis and nuclear structure investigations. Most of the measurements are conducted on 250Cf. In addition, the isotope shift of the isotopic chain 249−252Cf is measured for one transition. The identification and analysis of Rydberg series enables the determination of the first ionization potential of californium to EIP=50,666.76(5)cm−1. This is about a factor of 20 more precise than the current literature value.

The β−-particle-emitting erbium-169 is a potential radionuclide toward therapy of metastasized cancer diseases. It can be produced in nuclear research reactors, irradiating isotopically-enriched 168Er2O3. This path, however, is not suitable for receptor-targeted radionuclide therapy, where high specific molar activities are required. In this study, an electromagnetic isotope separation technique was applied after neutron irradiation to boost the specific activity by separating 169Er from 168Er targets. The separation efficiency increased up to 0.5% using resonant laser ionization. A subsequent chemical purification process was developed as well as activity standardization of the radionuclidically pure 169Er. The quality of the 169Er product permitted radiolabeling and pre-clinical studies. A preliminary in vitro experiment was accomplished, using a 169Er-PSMA-617, to show the potential of 169Er to reduce tumor cell viability.